As of 14-July-2022:
S&P 500 Index Fund: -19.97% -> -16.2%
Hong Kong Tracker Fund: -6.18% -> -5.65%
Straits Times Index Fund: 0.53% -> 1.4%
My portfolio: -2.63% -> -5.49%
Notable Transactions:
-Complete divestment of TTJ due to forceful acquisition of shares. I have tendered all but a token amount of them (in my SCB trading account). More on this in a latter section.
-Slight increase in Embecta.
-Increase in YZJ Finance in CPF due to the impending liquidation of TTJ
General Commentary
It does feel like my investments are largely inline with market performance. Most market participants would tell you that the first half of 2022 is horrid.
Superficially, my portfolio reported a 40% gain at the end of 2021. But really...the nightmare started in 2021 itself, right after the start of 2nd half 2021.
This is the trailing 12 month performance as captured by Stocks.Cafe
It should be much lower than 33%, had I not have such a huge stake in OKP (largely illiquid stock), and the 20+% upward price revision by TTJ (although it was a ridiculously low ball offer, and felt more like a loss than a gain).
What was responsible? In short, China. Bulk of the poor performance could be attributed to 4 stocks. Alibaba, Central China Management, Central China Ltd and Didi Global.
After divesting my stake in Perfect Shape (now called Perfect Medical) for a handsome gain, I was looking to put the funds to use. Now... success is a very bad teacher. I was laxed in my valuation.
Purchases in Alibaba started in Aug 2021, at the price of 160-ish HKD. We knew the price fell to 72 HKD. Through my persistent (and foolish?) buying as price fall day after day, my average price is now 115 HKD. I had to endure a 30% paper loss for most part, and reflect on why I had not insist on a larger margin of safety. Alibaba has since regain ground but appears to be selling off again for the last two trading days.
Central China Management (9982) and Central China Real Estate had a far, far worse fate. CCMGT was purchased from 1.77 HKD. Today it is only worth 0.88 HKD. Purchases for CCRE started at 1.17 and today it is worth half... at 0.58. Both of these are large positions. At present prices, it makes up for 13.7% of the entire portfolio (in terms of value). But on a cost basis, it is actually about 19%.
The case with Didi Global has been mentioned before so I shall not repeat it here.
With the exception of Central China RE (which I sold my parents' stake and reimburse them for the loss out of my own pocket, I do not wish for them to be exposed to this risk), I had not sell a single share for the rest of the counters. Unlike the sold down experienced by tech stock holders, these companies mentioned did not enjoy the post-COVID boom since 2020, and have contribute nothing but losses to my net worth. More frustratingly, none of them were bought during "good times."
China is also responsible for another holding of mine-- YZJ Finance Holdings. Over a span of two months, it managed to make a 20% gain, only for it to crumble again amidst China's debt issues again. The position is now in red.
Overall, there were no mercy from the markets in 22-H1... and it had been a year of continuous bad news.
Various positions in American exchange did not do well and all of them, except for the arbitrage position in Activision, is in loss of around 10-15%.
a) most market participants are not long term share holders. If they were, their annualized returns would have been low to normal due to lengthy time that share prices are depressed.
No comments:
Post a Comment